Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event.

Carrie YeKevin LeeWilliam D LeslieMu LinJohn WalkerMichael Kolinsky

Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)

Fracture risk may be increased in cancer patients early after initiation of ICI, and this may represent a novel immune-related adverse event.

Keyphrases

adverse drug
risk assessment
drug induced
breast cancer risk